Adage Capital Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Adage Capital Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,500,000	Closed	-$325M	–	1158
2021 Q1	$325M	Buy	+1,500,000	New	+$282M	0.66%	20
2019 Q4	–	Sell	-50,000	Closed	-$5.75M	–	781
2019 Q3	$5.75M	Buy	+50,000	New	+$7.59M	0.01%	614

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Adage Capital Partners's GWPH Position: Q2 2021 in Review

Adage Capital Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,500,000 shares — an estimated $325M sold.

Adage Capital Partners first reported a position in GWPH in Q3 2019 and held it in 2 quarters. The position peaked at $325M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Adage Capital Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Adage Capital Partners sold 1,500,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $325M.
Adage Capital Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 2 quarters.
Adage Capital Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $325M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.